D. Phippard's Profile

Role	Title	Level	Year	L/R
🐜	Efficacy of remission-induction regimens for ANCA-associated vasculitis. 31 auth. U. Specks, P. Merkel, P. Seo, R. Spiera, C. Langford, G. Hoffman, C. Kallenberg, E. S. St Clair, B. Fessler, L. Ding, L. Viviano, N. Tchao, D. Phippard, A. Asare, N. Lim, ... D. Ikle, B. Jepson, P. Brunetta, N. Allen, F. Fervenza, D. Geetha, K. Keogh, E. Kissin, P. Monach, T. Peikert, C. Stegeman, S. Ytterberg, Mark Mueller, Lourdes P. Sejismundo, Kathleen Mieras, J. Stone	9	2013	9 🐜
🐜	Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function 19 auth. S. A. Long, M. Rieck, S. Sanda, J. Bollyky, P. Samuels, R. Goland, A. Ahmann, A. Rabinovitch, S. Aggarwal, D. Phippard, ... L. Turka, L. Turka, M. Ehlers, P. Bianchine, Karen D. Boyle, S. Adah, J. Bluestone, J. Buckner, C. Greenbaum	8	2012	8 🐜
🐜	Differential inhibition of fracture healing by non‐selective and cyclooxygenase‐2 selective non‐steroidal anti‐inflammatory drugs 8 auth. L. Gerstenfeld, M. Thiede, K. Seibert, Cindy Mielke, D. Phippard, Bohus Svagr, ... D. Cullinane, T. Einhorn	8	2003	8 🐜
🐜	Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial 13 auth. K. Herold, S. Gitelman, M. Ehlers, P. Gottlieb, C. Greenbaum, W. Hagopian, Karen D. Boyle, L. Keyes‐Elstein, S. Aggarwal, D. Phippard, ... P. Sayre, J. Mcnamara, J. Bluestone	8	2013	8 🐜
🐜	T cell repertoire following autologous stem cell transplantation for multiple sclerosis. 11 auth. P. Muraro, H. Robins, Sachin Malhotra, Michael Howell, D. Phippard, C. Desmarais, ... Alessandra de Paula Alves Sousa, Linda M. Griffith, N. Lim, R. Nash, L. Turka	7	2014	7 🐜
🐜	Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients. 27 auth. Mark R Rigby, Kristina M Harris, A. Pinckney, L. Dimeglio, Marc S Rendell, E. Felner, J. Dostou, S. Gitelman, Kurt J. Griffin, E. Tsalikian, Peter A. Gottlieb, Carla J. Greenbaum, Nicole A. Sherry, Wayne V Moore, R. Monzavi, ... Steven M. Willi, P. Raskin, L. Keyes‐Elstein, S. A. Long, S. Kanaparthi, N. Lim, D. Phippard, Carol L. Soppe, Margret L. Fitzgibbon, J. Mcnamara, G. T. Nepom, M. Ehlers	7	2015	7 🐜
🐬	Developmental and hormonal regulation of Wnt gene expression in the mouse mammary gland. S. Weber-Hall, D. Phippard, C. Niemeyer, T. Dale	7	1994	7 🐬
🐜	HGF/SF: a potent cytokine for mammary growth, morphogenesis and development. 9 auth. B. Niranjan, L. Buluwela, J. Yant, N. Perusinghe, A. Atherton, D. Phippard, ... T. Dale, B. Gusterson, T. Kamalati	7	1995	7 🐜
🦁	Targeted Mutagenesis of the POU-Domain GeneBrn4/Pou3f4 Causes Developmental Defects in the Inner Ear D. Phippard, Lihui Lu, Daniel Lee, James C. Saunders, E. B. Crenshaw	7	1999	7 🦁
🐜	High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report. 19 auth. R. Nash, G. Hutton, M. Racke, U. Popat, S. Devine, Linda M. Griffith, P. Muraro, H. Openshaw, P. Sayre, O. Stüve, ... D. Arnold, M. Spychala, K. McConville, Kristina M. Harris, D. Phippard, G. Georges, A. Wundes, G. Kraft, J. Bowen	7	2015	7 🐜
🐜	Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial. 27 auth. M. Rigby, L. Dimeglio, M. Rendell, E. Felner, J. Dostou, S. Gitelman, Chetanbabu M Patel, K. Griffin, E. Tsalikian, P. Gottlieb, C. Greenbaum, N. Sherry, W. Moore, R. Monzavi, S. Willi, ... P. Raskin, A. Moran, W. Russell, A. Pinckney, L. Keyes‐Elstein, M. Howell, S. Aggarwal, N. Lim, D. Phippard, G. Nepom, J. Mcnamara, M. Ehlers	7	2013	7 🐜